I hope that shareholders recognize how favorable this $2 million unsecured loan is for BLR. In today's market where many juniors can't get funding at all, this loan is extremely attractive. Most juniors, (globally, not just ASX-listed) would have had to secure a loan like this. The loan would be convertible anytime and perhaps have warrants attached. The lender would have charged an arrangement fee of 2%-6%.
BLR's loan is NON-CONVERTIBLE until the maturity date, which is 24 months after the initial drawdown of the loan facility. This is not a typical convertible bond! Alex is giving BLR 2 years to pay back the loan without any equity dilution at all. Zero equity dilution for at least 2 years.
This is a material de-risking event. Add to that BLR's press release that states or implies in multiple ways that many prospective customers are very interested in Ablation's technology, and I think that last week's news was highly significant.
In the junior markets for coal, iron ore, potash, uranium, gold, etc, etc. in London, Canada, the U.S. and Australia, there's been nothing but horror. Thus, I'm not at all surprised that BLR stock did not move much upon the announcement.
Still, one day, hopefully in 2013, BLR will put out a press release announcing its first commercial contract with Cameco or Paladin or Rio Tinto or Areva or someone else for 1 or more Ablation units. One better be a holder of BLR stock on that day, otherwise one could miss a big gain.
In my opinion, any of the above named companies could have an appetite for several 20tph-50tph units.
I hope that shareholders recognize how favorable this $2 million...
Add to My Watchlist
What is My Watchlist?